Development and Evaluation of Novel Floating Drug Delivery Systems of Metoclopramide Hydrochloride

DOI:

https://doi.org/10.37285/ijpsn.2011.4.3.5

Authors

  • Vinay Wamorkar
  • A Samar
  • A Reddy
  • Anusha Ch
  • C V Saikrishna
  • Santoshkumar N

Abstract

Several distinct novel drug delivery systems are being employed for effective delivery of medications to patients. Oral delivery is by far the most preferable route of drug delivery and oral sustained-release gastroretentive drug delivery systems offer several advantages. These drug delivery systems are beneficial for drugs with absorption from the upper parts of the gastrointestinal tract and for those acting locally in the stomach, improving the bioavailability of these drugs. Floating drug delivery systems (FDDS) are one of the gastroretentive drug delivery systems used to achieve prolonged gastric residence time. Multiple unit FDDS avoid the “all-or-none” gastric emptying nature of single unit systems. In the present research study, floating formulation as solid (capsule) or liquid (in situ gel) drug delivery systems were developed for improving the gastric residence time of the anti-emetic agent metoclopramide hydrochloride. Floating capsules were prepared using combinations of various natural and synthetic polymers. Simultaneously, in situ gel was prepared using completely bio-degradable natural polymers. Both systems were able to sustain drug release for up to 8 hours. These formulations were compared with marketed forms and found to be more convenient from a patient as well as a biopharmaceutical standpoint. To assess the stability of these formulations, accelerated stability testing was conducted as per ICH guidelines. Both formulations were found to be stable upon completion of the accelerated stability period.   

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Oral delivery, floating capsule, in situ gel, metoclopramide, ICH guidelines

Downloads

Published

2011-11-30

How to Cite

1.
Wamorkar V, Samar A, Reddy A, Ch A, Saikrishna CV, N S. Development and Evaluation of Novel Floating Drug Delivery Systems of Metoclopramide Hydrochloride. Scopus Indexed [Internet]. 2011 Nov. 30 [cited 2024 Dec. 10];4(3):1470-7. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/439

Issue

Section

Research Articles

References

Ali J et al. (2008). Formulation and development of floating capsules of celecoxib: in vitro and in vivo evaluation. AAPS PharmSciTech; 4: Article 119.

Al-Tahami K and Singh J (2007). Smart polymer based systems for peptide and protein. Recent Pat Drug Deliv Formul 1:66-67.

Bhise SB and Aloorkar NH (2008). Formulation and in vitro evaluation of floating capsules of theophylline. Ind J Pharm Sci 70(2):225-227.

BP (2009). British Pharmacopoeia, Metoclopramide hydrochloride. Volume II: 3921-3923.

Jain N. K (2008). Controlled and Novel Drug Delivery. CBS Publishers and Distributors 3-4.

Korsmeyer R W, Deolkar G E, and Peppas N A (1983). Mechanisms of potassium chloride from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci 72:1189-1191.

Patel R P, et al. (2010). Formulation, evaluation and optimization of stomach specific in situ gel of Clarithromycin and Metronidazole benzoate. Int. J. Drug Deliv. 141-153.

Peppas NA and Langer R (1994). New challenges in biomaterial. Science 263:1715-1720.

Satoskar RS and Bhandarkar S (2008). Pharmacology and Pharmacotherapeutics. Popular Prakashan, Revised 21st Edition.587-588.

Saxena M (2009). Formulation and evaluation of transdermal patches of metoclopramide hydrochloride. Indian Drugs 43:9:740-743.

Zhidong L, et al (2006). Study of an alginate/HPMC based in situ gelling ophthalmic delivery system for gatifloxaein. Int J Pharm 315:12-17.